Osteoclast (OC) precursors migrate to putative sites of bone resorption to form functionally active, multinucleated cells. The preOC FLG 29.1 cells, known to be capable of irreversibly differentiating into multinucleated OC-like cells, displayed several features of primary OCs, including expression of specific integrins and the hyaluronan (HA) receptor CD44. OC-like FLG 29.1 cells adhered to and extensively migrated through membranes coated with fibronectin, vitronectin, and laminins, but, although strongly binding to HA, totally failed to move on this substrate. Moreover, soluble HA strongly inhibited OC-like FLG 29.1 cell migration on the permissive matrix substrates, and this behavior was dependent on its engagement with CD44, as it was fully restored by function-blocking anti-CD44 antibodies. HA did not modulate the cell–substrate binding affinity/avidity nor the expression levels of the corresponding integrins. MMP-9 was the major secreted metalloproteinase used by OC-like FLG 29.1 cells for migration, because this process was strongly inhibited by both TIMP-1 and GM6001, as well as by MMP-9–specific antisense oligonucleotides. After HA binding to CD44, a strong down-regulation of MMP-9 mRNA and protein was detected. These findings highlight a novel role of the HA–CD44 interaction in the context of OC-like cell motility, suggesting that it may act as a stop signal for bone-resorbing cells.
Skip Nav Destination
Article navigation
16 September 2002
Article|
September 16 2002
Hyaluronan–CD44 interaction hampers migration of osteoclast-like cells by down-regulating MMP-9
Paola Spessotto,
Paola Spessotto
1Divisione di Oncologia Sperimentale 2, CRO-IRCCS, National Cancer Institute, 33081 Aviano, Italy
Search for other works by this author on:
Francesca Maria Rossi,
Francesca Maria Rossi
2Nucleo di Ricerca Clinica e Laboratoristica in Ematologia, CRO-IRCCS, National Cancer Institute, 33081 Aviano, Italy
Search for other works by this author on:
Massimo Degan,
Massimo Degan
2Nucleo di Ricerca Clinica e Laboratoristica in Ematologia, CRO-IRCCS, National Cancer Institute, 33081 Aviano, Italy
Search for other works by this author on:
Raffaele Di Francia,
Raffaele Di Francia
2Nucleo di Ricerca Clinica e Laboratoristica in Ematologia, CRO-IRCCS, National Cancer Institute, 33081 Aviano, Italy
Search for other works by this author on:
Roberto Perris,
Roberto Perris
1Divisione di Oncologia Sperimentale 2, CRO-IRCCS, National Cancer Institute, 33081 Aviano, Italy
3Dipartimento di Biologia Evolutiva Funzionale, University of Parma, 43100 Parma, Italy
Search for other works by this author on:
Alfonso Colombatti,
Alfonso Colombatti
1Divisione di Oncologia Sperimentale 2, CRO-IRCCS, National Cancer Institute, 33081 Aviano, Italy
4Dipartimento di Scienze e Tecnologie Biomediche, University of Udine, 33100 Udine, Italy
5MATI Center of Excellence, University of Udine, 33100 Udine, Italy
Search for other works by this author on:
Valter Gattei
Valter Gattei
2Nucleo di Ricerca Clinica e Laboratoristica in Ematologia, CRO-IRCCS, National Cancer Institute, 33081 Aviano, Italy
Search for other works by this author on:
Paola Spessotto
1Divisione di Oncologia Sperimentale 2, CRO-IRCCS, National Cancer Institute, 33081 Aviano, Italy
Francesca Maria Rossi
2Nucleo di Ricerca Clinica e Laboratoristica in Ematologia, CRO-IRCCS, National Cancer Institute, 33081 Aviano, Italy
Massimo Degan
2Nucleo di Ricerca Clinica e Laboratoristica in Ematologia, CRO-IRCCS, National Cancer Institute, 33081 Aviano, Italy
Raffaele Di Francia
2Nucleo di Ricerca Clinica e Laboratoristica in Ematologia, CRO-IRCCS, National Cancer Institute, 33081 Aviano, Italy
Roberto Perris
1Divisione di Oncologia Sperimentale 2, CRO-IRCCS, National Cancer Institute, 33081 Aviano, Italy
3Dipartimento di Biologia Evolutiva Funzionale, University of Parma, 43100 Parma, Italy
Alfonso Colombatti
1Divisione di Oncologia Sperimentale 2, CRO-IRCCS, National Cancer Institute, 33081 Aviano, Italy
4Dipartimento di Scienze e Tecnologie Biomediche, University of Udine, 33100 Udine, Italy
5MATI Center of Excellence, University of Udine, 33100 Udine, Italy
Valter Gattei
2Nucleo di Ricerca Clinica e Laboratoristica in Ematologia, CRO-IRCCS, National Cancer Institute, 33081 Aviano, Italy
Address correspondence to Alfonso Colombatti, Divisione di Oncologia Sperimentale 2 CRO-IRCCS, National Cancer Institute, 33081 Aviano, Italy. Tel.: 39-0434-659-365. Fax: 39-0434-659-428. E-mail: [email protected]
*
Abbreviations used in this paper: CAFCA, centrifugal assay for fluorescence-based cell adhesion; FN, fibronectin; HA, hyaluronan; LN, laminin; MMP, matrix metalloproteinase; OC, osteoclast; preOC, preosteoclast; TIMP-1, tissue inhibitor of metalloproteinase 1; TPA, 12-O-tetradecanoylphorbol-13-acetate; VN, vitronectin.
Received:
February 26 2002
Revision Received:
July 16 2002
Accepted:
August 05 2002
Online ISSN: 1540-8140
Print ISSN: 0021-9525
The Rockefeller University Press
2002
J Cell Biol (2002) 158 (6): 1133–1144.
Article history
Received:
February 26 2002
Revision Received:
July 16 2002
Accepted:
August 05 2002
Citation
Paola Spessotto, Francesca Maria Rossi, Massimo Degan, Raffaele Di Francia, Roberto Perris, Alfonso Colombatti, Valter Gattei; Hyaluronan–CD44 interaction hampers migration of osteoclast-like cells by down-regulating MMP-9 . J Cell Biol 16 September 2002; 158 (6): 1133–1144. doi: https://doi.org/10.1083/jcb.200202120
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionEmail alerts
Advertisement
Advertisement